Overview Personalized medicine trials don’t fit the standard RTSM software model. When every patient receives a custom-manufactured therapy, the supply..
Overview Personalized medicine trials don’t fit the standard RTSM software model. When every patient receives a custom-manufactured therapy, the supply..
Overview A clinical-stage genetic medicines company is pioneering precision delivery technologies for mRNA and gene correction therapeutics. They are developing..
Overview A clinical-stage oncology biotech was running a live Phase I study using manual enrollment and drug supply workflows, with..
Overview A clinical-stage oncology biotech running early Phase I studies needed an RTSM software that could keep pace with a..
The Hidden Cost of Unintentional Unblinding in Clinical Trials In blinded clinical trials, protecting treatment assignment data is essential. Yet across the Randomization..
If you work in clinical operations long enough, you start to notice the same pattern repeat. On the surface, many RTSM systems..
When Sponsors evaluate RTSM software for their clinical trial, early conversations tend to center on platform features, timelines, and cost…
In the world of clinical operations, bigger often feels safer. Familiar brand names, multi-asset platforms, and providers with a decade or more..
On the surface, an “all-in-one” eClinical platform sounds like the dream. One vendor, one contract, one login, everything in one place. For busy study..
Key Takeaways Mid-study RTSM migration is feasible and strategic for preserving trial integrity amid growing study complexity. Signs to change..